Life Technologies Corporation, a Carlsbad, California based company, has announced the launch of their bench top “Ion Proton Sequencer”, a pH-based sequencing device designed to… Read More »Life Technologies Corp schedules $1,000 genome before the end of 2012
Valeant Pharmaceuticals International Inc. (TSX: VRX; NYSE: VRX), an Ontario-based pharmaceuticals company with an estimated value in excess of $13 billion, has made public an… Read More »Valeant Pharmaceuticals International makes hostile takeover bid for eye care business, Ista Pharmaceuticals
VisionCare Ophthalmic Technologies (Saratoga, California) have announced that their FDA-approved Implantable Miniature Telescope (IMT) has been implanted into the first patient. The IMT device is… Read More »VisionCare Ophthalmic Technologies announces first patient to receive Implantable Miniature Telescope
A Florida based clinical stage biotechnology company – Applied Genetic Technologies Corporation (AGTC) has announced the receipt of $1.5M in funding from the US Foundation… Read More »AGTC receives $1.5M boost from Foundation Fighting Blindness to progress gene therapy for X-linked retinoschisis
iScience Interventional, a private device and imaging company in Menlo Park, California, have announced the execution of a clinical and commercial supply agreement with Johnson… Read More »iScience Interventional announces micro-catheter supply deal with J&J for cell therapy AMD trial
Roche (SIX:ROG; OTCQX:RHHBY) has reported that 3Q11 US sales of Lucentis (ranibizumab) grew by 17% to CHF359M/US$392M. The increase in sales occurs against the backdrop… Read More »Roche sees Lucentis sales increase and announces data from Phase III HARBOR trial
UK company Optos, plc (LSE: OPTS) has announced its next generation imaging device, branded “Daytona”, at the Boston meeting of the American Academy of Optometry.… Read More »Optos, plc unveils next generation desktop imaging device at American Academy of Optometry meeting
VisionCare Ophthalmic Technologies, Inc., a specialty medical device company based in Saratoga California, have announced that the Centres for Medicare and Medicaid Services (CMS), a… Read More »VisionCare’s implantable telescope secures reimbursement
A new UK-based ophthalmology company – KalVista Pharmaceuticals – has announced the completion of an £8 million Series A funding round led by Novo A/S… Read More »A new ophthalmic company – KalVista Pharmaceuticals – raises £8M to fund DME therapies
iCo Therapeutics (TSX-V: ICO, Vancouver, Canada) has announced the execution of a licensing deal with Immune Pharmaceuticals (Ness-Ziona, Israel) for Bertilimumab (iCo-008) for systemic uses.… Read More »iCo Therapeutics enters license deal with Immune Pharmaceuticals